MEN1 Deficiency‐Driven Activation of the β‐Catenin‐MGMT Axis Promotes Pancreatic Neuroendocrine Tumor Growth and Confers Temozolomide Resistance

Xu et al. (Tue,) studied this question.

www.synapsesocial.com/papers/68e5f50bb6db6435875899ce — DOI: https://doi.org/10.1002/advs.202308417

Also consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. Regulation of expression of the DNA repair gene O6-methylguanine-DNA methyltransferase via protein kinase C-mediated signaling.· 1998 · 94 citations
2. Safety, tolerability, and anti-fibrotic efficacy of the CBP/β-catenin inhibitor PRI-724 in patients with hepatitis C and B virus-induced liver cirrhosis: An investigator-initiated, open-label, non-randomised, multicentre, phase 1/2a study· 2022 · 54 citations
3. Nuclear-Cytoplasmic Shuttling of Menin Regulates Nuclear Translocation of β-Catenin· 2009 · 115 citations
4. MEN1 in pancreatic endocrine tumors: analysis of gene and protein status in 169 sporadic neoplasms reveals alterations in the vast majority of cases· 2010 · 169 citations
5. Modulating MGMT expression through interfering with cell signaling pathways· 2023 · 26 citations